Low dose Cyclosporin A treatment increases live birth rate of unexplained recurrent abortion - initial cohort study

Abstract

Low-dose CsA treatment increases live birth rate of unexplained recurrent abortion. No maternal-fetal adverse consequence was observed in this study and it is safe in clinic use. The mechanism of CsA therapy may be related to immune regulation which may favor the success of pregnancy.